The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Breier, A.
* Articles by Pickar, D.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Breier, A.
* Articles by Pickar, D.

Am J Psychiatry 1990; 147:1467-1470
Copyright © 1990 by American Psychiatric Association


REGULAR ARTICLES

Plasma norepinephrine in chronic schizophrenia

A Breier, OM Wolkowitz, A Roy, WZ Potter and D Pickar
Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD 21228.

Several lines of evidence indicate altered noradrenergic function in schizophrenia. The authors examined resting, standing, and change (standing minus resting) in plasma norepinephrine levels in 14 drug- free patients with chronic schizophrenia or schizoaffective disorder and in 33 age- and sex-matched healthy volunteers. Schizophrenic patients had significantly higher resting and standing plasma norepinephrine levels and significantly greater change. Resting and standing levels were significantly related to positive and negative symptoms. There was a significant positive correlation between resting plasma and CSF norepinephrine levels and a significant negative correlation between CSF homovanillic acid and resting, standing, and change in plasma norepinephrine levels.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
V. P. Bakshi and M. A. Geyer
Phencyclidine-Induced Deficits in Prepulse Inhibition of Startle are Blocked by Prazosin, an Alpha-1 Noradrenergic Antagonist
J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 666 - 674.
[Abstract] [Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1990 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org